Birdwatch Note
2023-10-06 19:13:55 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Misleading claim. When manufacturers scale up, which happens in every drug’s development pipeline, the two products have to be shown to be equivalent by undergoing the same GMP characterization assays in which the products are *demonstrated* to be equivalent. https://ascendiapharma.com/newsroom/how-to-scale-up-pharmaceutical-manufacturing#:~:text=Scaling%20up%20pharmaceutical%20manufacturing%20refers,size%20of%20equipment%20and%20vessels
Written by 49C6CCBC611F3793DAE5D41CE4AF4685C99C78745D6078D4A8B41FEB8655383D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1710345850877071480
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1710372835833840005
- noteId - 1710372835833840005
- participantId -
- noteAuthorParticipantId - 49C6CCBC611F3793DAE5D41CE4AF4685C99C78745D6078D4A8B41FEB8655383D Participant Details
- createdAtMillis - 1696619635910
- tweetId - 1710345850877071480
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Misleading claim. When manufacturers scale up, which happens in every drug’s development pipeline, the two products have to be shown to be equivalent by undergoing the same GMP characterization assays in which the products are *demonstrated* to be equivalent. https://ascendiapharma.com/newsroom/how-to-scale-up-pharmaceutical-manufacturing#:~:text=Scaling%20up%20pharmaceutical%20manufacturing%20refers,size%20of%20equipment%20and%20vessels
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-10-06 19:13:55 UTC (1696619635910) |
1969-12-31 23:59:59 UTC (-1) |
2023-10-07 02:42:31 UTC (1696646551297) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-10-06 18:51:15 -0500 | Rating Details | |
| 2023-10-06 17:45:53 -0500 | Rating Details | |
| 2023-10-06 17:09:56 -0500 | Rating Details | |
| 2023-10-06 17:03:49 -0500 | Rating Details | |
| 2023-10-06 16:55:25 -0500 | Rating Details | |
| 2023-10-06 16:44:25 -0500 | Rating Details | |
| 2023-10-06 16:38:16 -0500 | Rating Details | |
| 2023-10-06 16:22:15 -0500 | Rating Details | |
| 2023-10-06 16:11:50 -0500 | Rating Details | |
| 2023-10-06 16:11:40 -0500 | Rating Details | |
| 2023-10-06 16:07:49 -0500 | Rating Details | |
| 2023-10-06 16:06:37 -0500 | Rating Details | |
| 2023-10-06 16:06:36 -0500 | Rating Details | |
| 2023-10-06 15:55:34 -0500 | Rating Details | |
| 2023-10-06 15:46:53 -0500 | Rating Details | |
| 2023-10-06 15:46:00 -0500 | Rating Details | |
| 2023-10-06 15:34:25 -0500 | Rating Details | |
| 2023-10-06 15:19:51 -0500 | Rating Details | |
| 2023-10-06 15:19:12 -0500 | Rating Details | |
| 2023-10-06 15:09:57 -0500 | Rating Details | |
| 2023-10-06 14:36:53 -0500 | Rating Details | |
| 2023-10-06 14:20:16 -0500 | Rating Details | |
| 2023-10-06 14:19:29 -0500 | Rating Details | |
| 2023-10-06 14:18:08 -0500 | Rating Details | |
| 2023-10-06 14:15:05 -0500 | Rating Details | |
| 2023-10-07 13:52:50 -0500 | Rating Details | |
| 2023-10-07 10:26:12 -0500 | Rating Details | |
| 2023-10-07 09:59:14 -0500 | Rating Details | |
| 2023-10-07 07:42:33 -0500 | Rating Details | |
| 2023-10-07 07:32:16 -0500 | Rating Details | |
| 2023-10-07 07:16:48 -0500 | Rating Details | |
| 2023-10-07 07:14:21 -0500 | Rating Details | |
| 2023-10-07 06:55:38 -0500 | Rating Details | |
| 2023-10-07 06:34:49 -0500 | Rating Details | |
| 2023-10-07 05:36:54 -0500 | Rating Details | |
| 2023-10-07 05:19:26 -0500 | Rating Details | |
| 2023-10-07 04:27:07 -0500 | Rating Details | |
| 2023-10-07 02:32:50 -0500 | Rating Details | |
| 2023-10-07 01:44:15 -0500 | Rating Details | |
| 2023-10-06 23:58:43 -0500 | Rating Details | |
| 2023-10-06 23:54:43 -0500 | Rating Details | |
| 2023-10-06 23:54:20 -0500 | Rating Details | |
| 2023-10-06 23:26:25 -0500 | Rating Details | |
| 2023-10-06 23:09:25 -0500 | Rating Details | |
| 2023-10-06 21:38:50 -0500 | Rating Details | |
| 2023-10-06 21:19:51 -0500 | Rating Details | |
| 2023-10-06 21:15:15 -0500 | Rating Details | |
| 2023-10-06 21:06:00 -0500 | Rating Details | |
| 2023-10-06 20:57:24 -0500 | Rating Details | |
| 2023-10-06 20:38:04 -0500 | Rating Details | |
| 2023-10-06 20:29:31 -0500 | Rating Details | |
| 2023-10-06 20:21:13 -0500 | Rating Details | |
| 2023-10-06 20:20:23 -0500 | Rating Details | |
| 2023-10-06 20:19:28 -0500 | Rating Details | |
| 2023-10-06 20:18:19 -0500 | Rating Details | |
| 2023-10-06 20:15:19 -0500 | Rating Details | |
| 2023-10-06 19:34:19 -0500 | Rating Details | |
| 2023-10-08 04:26:35 -0500 | Rating Details |